Pharmedium Recalls Adenosine Injection Due to Sterility Assurance Concerns
Pharmedium Services, LLC is recalling all lots of Adenosine Injection because of a lack of sterility assurance. The recall covers products distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury/property-damage reports or high-risk conditions like sterility assurance issues in injectable drugs are rated as Severe (4).
Plain-English summary
Pharmedium Services, LLC is voluntarily recalling Adenosine Injection in all strengths, doses, and packaging. The recall is being conducted due to a lack of sterility assurance. The affected products were distributed nationwide in the United States.
The recall includes all lots of the product that remain within their expiration dates. The source text does not specify the number of units recalled or the specific dates of distribution.
Consumers and healthcare providers should stop using the recalled Adenosine Injection and contact their pharmacist or healthcare provider for guidance on replacement or disposal. No illnesses or injuries have been reported in the source text.
The recalled product
- Product
- Adenosine Injection in all strengths, all doses, and all packaging.
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots remaining within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Infusions Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24
Similar recalls
- SeverePharmakon Recalls Adenosine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SeverePharMEDium Recalls Phenylephrine Injection Due to Sterility Assurance Failure
FDA (Drugs) · 2018-02-21
- SevereDexpanthenol Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2018-11-07
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SevereOlympia Pharmacy Recalls Adenosine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SeverePromise Pharmacy Recalls Amino Blend Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20